Rick Johnson's company is developing fructokinase inhibitors for metabolic syndrome and fructose-associated conditions.

Every Sunday: the week’s new conflicts and verdict changes — and nothing else.

Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.